WebJan 13, 2016 · About bioTheranostics bioTheranostics, Inc., is a leader in helping physicians improve the care of cancer patients, offering a suite of proprietary molecular diagnostic tests that allow treatment ... WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in …
Biotheranostics, Inc. A Hologic Company
WebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ... WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … trust exercise ending explained reddit
Personalized Medicines In Oncology Market - MarketWatch
WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into … WebJan 5, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support … WebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic ... philips 19hfl5114w